Skip to content
Our Latest News, Case Studies, Webinars & More
What the new BIS 50% Rule Means for Third-Party Screening & Ownership Due Diligence
On September 29, 2025, the Bureau of Industry and Security of the US Department of Commerce (“BIS”) issued a new interim final rule [...]
The Importance of TPRM in Facilitating Ethical Transactions with HCPs
In the Life Sciences industry, maintaining ethical and transparent relationships with healthcare professionals (HCPs) is fundamental to trust, patient safety, and business integrity. [...]
Agility, Innovation & Strong (Ethical) Foundations
Earlier this month, Ethixbase360 was delighted to sponsor the third annual Risk & Compliance Pharma & Life Sciences Conference, held in London. [...]
The Business Value of Tcertification
Virna Di Palma, Head of Global Content & Brand at Ethixbase360, highlights how Tcertification creates measurable business value.
Why Supply Chain Risk Management Matters
Peter Nestor, Global Head of Human Rights at Novartis, explains why managing supply chain risks is now central to business resilience.
CSDDD in Transition – Has the EU Omnibus Package Gone Too Far? What’s Next for Companies and Human Rights Compliance
As debate continues over the EU Omnibus Proposal—unlikely to be finalized before 2026—many companies are questioning whether the package has […]
How Third Party Risk Management Has Changed
Peter Sweetbaum, Former CEO at Ethixbase360, reflects on how TPRM has evolved with shifting regulatory and market pressures.
What Boards Expect from TPRM
Peter Sweetbaum, Former CEO at Ethixbase360, outlines the expectations boards now place on third-party risk programs.
